BHAGCHEM NSI Week ended 07 Aug 2026

Weekly Investor Report

Bhagiradha Chemicals & Industries Limited · Basic Materials · Agricultural Inputs

Open interactive chart View report data
Latest close 285.6 INR
-1.8% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 19.5% above the Trend Line and sits at 78.6% of its 52-week range. The latest completed week returned -1.8%, after a -3.4% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is expensive relative to peers. The latest news-sentiment score is 50/100.

Setup score 66 out of 100
Latest Close 285.6 INR 7 Aug 2026
1W Return -1.8% latest completed week
4W Return -3.4% short-term follow-through
12W Return 14.7% quarterly tape
Trend Breadth 21.2% 11 of 52 weeks active
Volume Ratio 2.5x vs 13-week average
What is working
  • The trend backdrop is active with a 11-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • No major top-level risk cluster is currently dominant.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -1.8% Latest completed week; four-week move -3.4%. Indicator stack 50/57 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 50/100 15 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 19.5% above the Trend Line and sits at 78.6% of its 52-week range. The latest completed week returned -1.8%, after a -3.4% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 2.5x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.8812-week average 0.67

12-week confirmation

Trend active11/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.88Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -3.4% over four weeks, 14.7% over 12 weeks, and -0.3% over one year. The current trend has remained active for 11 consecutive weeks.

Performance by holding period

1W-1.8%
4W-3.4%
12W14.7%
26W25.5%
52W-0.3%
Active trend streak11 weeks
Active weeks in one year11
Trend breadth21.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.66Latest activity-pressure read.
Pressure change-56.6%Four-week change in activity pressure.
Leadership18.47Latest relative-leadership reading.
RS change-23.0%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 88%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength5/100Blend of value, momentum, and quality. Underlying universe rank 96; rank 1 is best.
Value3/100Relative valuation strength. Underlying universe rank 98; rank 1 is best.
Quality13/100Profitability and accounting quality. Underlying universe rank 88; rank 1 is best.
Momentum65/100Medium-term price momentum. Underlying universe rank 36; rank 1 is best.
Growth84/100Revenue and earnings growth. Underlying universe rank 17; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework1/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
203.8x
Price divided by trailing earnings.
Price / sales
6.9x
Market value relative to trailing revenue.
EV / EBITDA
65.9x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-3.8%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
37.5%
Gross profit retained from each unit of revenue.
Operating margin
6.8%
Operating profit retained from revenue.
Free-cash-flow margin
-27.6%
Free cash flow generated from revenue.
Return on invested capital
3.0%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
21.7%
Latest one-year revenue growth.
EPS growth
31.1%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.1%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.1%
Dividend yield plus net buyback yield.
Net debt / EBITDA
3.7x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 15 relevant articles.

0 positive · 15 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-9.9%Distance below the 52-week high.
13-week volatility5.2%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+17.0%Week of 24 Apr.
Worst week-8.6%Week of 17 Jul.
Latest week-1.8%Week of 7 Aug.

Shape of recent returns

Strong gains6
Modest gains6
Flat weeks0
Modest losses10
Sharp losses4
Recent vol5.2%13-week weekly-return volatility.
Base vol5.4%52-week weekly-return volatility.
Up/down split23/29Count of positive and negative weeks in the 52-week window.
Average skew4.7% / -3.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape66/100

Trend, activity pressure, participation, and risk combine to a 66/100 tape read.

 Indicator analysis87/100

Latest 12-week confirmation: trend 11/12, activity pressure 12/12, relative leadership 12/12.

Activity pressure 0.88; No reversal markers Factors19/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 26; Small Cap Core rank 97 SVQF1/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 1580.0 of 1592 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 15 relevant articles.

Bhagiradha Chemicals Share Price: शेयरधारकों की बल्ले-बल्ले! पहली तिमाही में मुनाफे का रॉकेट, **60%** की उछाल! Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 2026285.6 INR-1.8%239.0 INR247.0 INR0.6618.471.9MOn
31 Jul 2026290.8 INR10.4%236.5 INR245.9 INR0.8621.49625.2KOn
24 Jul 2026263.5 INR-2.6%233.5 INR244.8 INR1.0112.85201.4KOn
17 Jul 2026270.3 INR-8.6%232.3 INR244.0 INR1.2612.95430.2KOn
10 Jul 2026295.7 INR4.4%231.0 INR243.1 INR1.5223.971.4MOn
3 Jul 2026283.2 INR0.5%228.7 INR242.1 INR1.4018.53104.1KOn
26 Jun 2026281.7 INR0.9%227.1 INR241.2 INR1.2418.860On
19 Jun 2026279.1 INR3.4%225.9 INR240.4 INR1.1617.974.4MOn
12 Jun 2026270.0 INR10.9%224.9 INR239.6 INR0.9815.96235.1KOn
5 Jun 2026243.5 INR-1.7%224.2 INR238.9 INR0.945.5050.4KOn
29 May 2026247.6 INR1.1%224.2 INR238.3 INR1.056.17244.3KOn
22 May 2026244.9 INR-1.7%224.2 INR237.8 INR1.153.81317.6KOff
15 May 2026249.1 INR-3.1%224.3 INR237.2 INR1.355.52226.3KOff
8 May 2026257.0 INR-3.0%224.1 INR236.6 INR1.396.19287.4KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context